News & Articles

AMSBIO announces the launch of a new range of circulating tumor DNA (ctDNA) reference standards for cancer disease management research

Exclusively licensed, rhabdovirus-free platform enables more productive bioprocessing

Join SelectScience and Dr. Richard Eglan for a specialist drug discovery webinar on 3D cell culture technology

Learn about the technologies advancing phenotypic screening at HCS Pharma

Learn how a company in Switzerland is harnessing the latest cell culture technology to build even more predictive 3D cellular models for respiratory disease research

Attend this free webinar to discover new imaging technology that enables true 3D high content analysis

Find out why PROTACs hold such promise in cancer drug discovery

Organoid expert reveals recent developments, benefits, and challenges in organoid research

3D imaging technology provides images of the cell cluster down to the nuclei while mitigating drug discovery risks

Your solution for quick and easy filtration of single-cell suspensions

Discover a comprehensive guide to real-time live-cell imaging and analysis

Development collaboration integrates Sartorius Stedim Biotech’s BIOSTAT® STR bioreactors and Repligen’s XCell™ ATF cell retention control technology

Find out about new tools and techniques to streamline biopharmaceutical analysis

Biotech scientist shares the importance of reliable technologies in the production of therapeutic proteins

Researchers reveal new insights into self repair pathways in cancer cells, after therapy with PARP inhibitors

Discover how scientists in Sweden and Finland are developing a functional systems precision medicine strategy to optimize treatment of acute myeloid leukemia

New 3D model provides options for drug development and treatment of gestational disorders

Dedicated facility developed in response to increasing demand for product development projects in diagnostics, R&D and bioprocess

Discover how 3D models of glioblastoma using patient-derived stem cells could enable more effective treatment

Watch the product launch video for more information

AMSBIO has announced an exosome isolation, manufacturing, and characterization service to enable R&D groups to accelerate their discovery and development activities